Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer's disease risk in the general population: a Mendelian randomisation study. (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00125-022-05743-0

PubMed Identifier: 35902387

Publication URI: http://europepmc.org/abstract/MED/35902387

Type: Journal Article/Review

Volume: 65

Parent Publication: Diabetologia

Issue: 10

ISSN: 0012-186X